Prospect-EPIC Utrecht: Study design and characteristics of the cohort population

被引:129
作者
Boker, LK [1 ]
van Noord, PAH [1 ]
van der Schouw, YT [1 ]
Koot, NVCM [1 ]
de Mesquita, HBB [1 ]
Riboli, E [1 ]
Grobbee, DE [1 ]
Peeters, PHM [1 ]
机构
[1] Univ Utrecht, Med Ctr, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands
关键词
characteristics; EPIC; nurition and cancer; Prospect-EPIC; study design; The Netherlands;
D O I
10.1023/A:1020009325797
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The European Prospective Investigation into Cancer and Nutrition (EPIC), which has been established in order to investigate the relations between nutrition and cancer, was initiated in 1990 and involves 10 European countries with heterogeneous dietary patterns and differing cancer incidence rates. This manuscript presents the design, recruitment and baseline characteristics of the Prospect-EPIC cohort co-ordinated in Utrecht, The Netherlands. The cohort is based on volunteers recruited among women participating in a regional breast cancer screening program. It comprises of 17,357 subjects aged 50-69 years at enrolment from Utrecht and vicinity, who have consented to participate in the study and its follow-up. Each participant filled out a general questionnaire and a food frequency questionnaire. Participants were also physically examined and have donated a blood sample. Participation rate was 34.5%. Blood samples were donated by most participants (97.5%) and detailed informed consents were obtained from 87.4% of participants. Mean age at enrolment was 57 years. Anthropometric, lifestyle and morbidity characteristics of the cohort population did not differ largely from those of similar study populations in The Netherlands. Based on the Prospect-EPIC population, we intend to conduct prospective total cohort, nested case-control or case-cohort studies, in order to investigate relations between consumption of certain food groups or nutrients and chronic diseases, including hormone dependant cancers such as breast, colon, endometrial and ovary cancers.
引用
收藏
页码:1047 / 1053
页数:7
相关论文
共 39 条
  • [1] Effects of supplemental α-tocopherol and β-carotene on colorectal cancer:: results from a controlled trial (Finland)
    Albanes, D
    Malila, N
    Taylor, PR
    Huttunen, JK
    Virtamo, J
    Edwards, BK
    Rautalahti, M
    Hartman, AM
    Barrett, MJ
    Pietinen, P
    Hartman, TJ
    Sipponen, P
    Lewin, K
    Teerenhovi, L
    Hietanen, P
    Tangrea, JA
    Virtanen, M
    Heinonen, OP
    [J]. CANCER CAUSES & CONTROL, 2000, 11 (03) : 197 - 205
  • [2] Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501
  • [3] NUTRITION INTERVENTION TRIALS IN LINXIAN, CHINA - SUPPLEMENTATION WITH SPECIFIC VITAMIN MINERAL COMBINATIONS, CANCER INCIDENCE, AND DISEASE-SPECIFIC MORTALITY IN THE GENERAL-POPULATION
    BLOT, WJ
    LI, JY
    TAYLOR, PR
    GUO, WD
    DAWSEY, S
    WANG, GQ
    YANG, CS
    ZHENG, SF
    GAIL, M
    LI, GY
    YU, Y
    LIU, BQ
    TANGREA, J
    SUN, YH
    LIU, FS
    FRAUMENI, JF
    ZHANG, YH
    LI, B
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (18): : 1483 - 1492
  • [4] BuenodeMesquita HB, 1997, EUR J CANCER PREV, V6, P107
  • [5] Risk factors for increased bone loss in an elderly population - The Rotterdam Study
    Burger, H
    de Laet, CEDH
    van Daele, PLA
    Weel, AEAM
    Witteman, JCM
    Hofman, A
    Pols, HAP
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1998, 147 (09) : 871 - 879
  • [6] Day N, 1999, BRIT J CANCER, V80, P95
  • [7] THE DOM PROJECT FOR THE EARLY DETECTION OF BREAST-CANCER, UTRECHT, THE NETHERLANDS
    DEWAARD, F
    COLLETTE, HJA
    ROMBACH, JJ
    BAANDERSVANHALEWIJN, EA
    HONING, C
    [J]. JOURNAL OF CHRONIC DISEASES, 1984, 37 (01): : 1 - 44
  • [8] THE CAUSES OF CANCER - QUANTITATIVE ESTIMATES OF AVOIDABLE RISKS OF CANCER IN THE UNITED-STATES TODAY
    DOLL, R
    PETO, R
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1981, 66 (06): : 1191 - +
  • [9] Fracheboud J, 1998, INT J CANCER, V75, P694, DOI 10.1002/(SICI)1097-0215(19980302)75:5<694::AID-IJC6>3.0.CO
  • [10] 2-U